Trial Profile
A trial to investigate the pharmacokinetic parameters of peginterferon Lambda-1A in chronic hepatitis C patients with renal impairment
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Peginterferon lambda-1a (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- 17 Dec 2015 New trial record